Congenital heart defects are structural abnormalities of the heart that develop during fetal development, affecting approximately 1 in 100 babies born in the UK. These conditions involve malformations of the heart’s chambers, valves, or major blood vessels that occur during the first eight weeks of pregnancy when the heart is forming. The severity ranges from simple defects that may never cause symptoms to complex abnormalities requiring immediate surgical intervention.

According to the NHS, some cases are simple and may not cause symptoms, while others can be life-threatening and require treatment in infancy. Healthcare providers can detect many heart defects early through prenatal screening, though sometimes diagnosis doesn’t occur until childhood or even adulthood.

Most congenital heart defects occur without a clear cause, developing during the critical period of heart formation in early pregnancy. Known risk factors include maternal infections such as rubella during pregnancy, certain medications, smoking or exposure to secondhand smoke, and maternal conditions like diabetes. Genetic factors also play a role, with some defects associated with chromosomal conditions like Down syndrome.

Family history increases risk, with studies showing that if one parent has a congenital heart defect, the risk for their children increases to between 3-6%. Environmental factors during pregnancy, including alcohol consumption and exposure to certain chemicals, may also contribute to the development of heart defects.

Prenatal diagnosis typically begins with routine anomaly scans around 18-22 weeks of pregnancy, which include examination of the fetal heart’s basic structure. When abnormalities are suspected or for high-risk pregnancies, specialist fetal echocardiography provides detailed assessment of heart structure and function using ultrasound techniques.

Additional testing may include NIPT screening to detect chromosomal conditions associated with heart defects, and in some cases, invasive diagnostic tests like amniocentesis may be recommended. Early diagnosis allows families to prepare for appropriate specialist care and delivery planning at centres equipped for immediate postnatal intervention if required.

Symptoms vary significantly depending on the type and severity of the heart defect. Some babies may show no symptoms initially, while others may experience cyanosis (bluish skin colour), difficulty feeding, poor weight gain, or rapid breathing. More severe defects may cause heart failure symptoms including excessive sweating, fatigue during feeding, or swelling.

The NHS recommends pulse oximetry testing as a potential screening tool for detecting congenital heart disease in newborns. Some defects only become apparent as children grow and their activity levels increase, while others require immediate medical attention from birth.

Most congenital heart defects are not directly inherited, but genetic factors do influence risk. Research published in medical journals shows that if one parent has a congenital heart defect, the risk for their children increases to 3-6% compared to the general population risk of 0.8%. The risk is higher when the affected parent is the mother.

Some heart defects are associated with genetic syndromes that follow inheritance patterns, such as Marfan syndrome which has a 50% recurrence risk. For families with a history of heart defects, genetic counselling can help assess individual risks and discuss available screening options during pregnancy.

Treatment varies widely depending on the type and severity of the defect. Some simple defects may require only monitoring, while others need immediate surgical intervention in the newborn period. Medications may be prescribed to strengthen heart function, improve oxygen levels in the blood, or manage symptoms like heart failure.

Many defects can be successfully repaired through surgical procedures, though some complex conditions require multiple operations throughout childhood and adulthood. Modern cardiac surgery has excellent outcomes for most congenital heart defects, allowing many individuals to lead normal, active lives with appropriate ongoing medical care.

Many women with congenital heart defects can have successful pregnancies, though pregnancy does place additional strain on the heart. According to the NHS, if you have heart disease you may be able to have a successful pregnancy, but careful medical supervision is essential throughout pregnancy and delivery.

Pre-pregnancy counselling is crucial to assess individual risks and optimise maternal health before conception. Some medications may need to be reviewed for safety during pregnancy, and delivery planning often involves specialist obstetric and cardiac teams. Enhanced monitoring throughout pregnancy helps ensure both maternal and fetal wellbeing.

The prognosis varies significantly depending on the specific type of defect and whether treatment is available. Many simple defects have excellent long-term outcomes with normal life expectancy and activity levels. More complex defects may require ongoing medical care and repeated interventions, but modern treatments have dramatically improved outcomes.

Adults with congenital heart disease require specialised follow-up care, as the NHS provides Adult Congenital Heart Disease services for people aged 16 and over. Many individuals with successfully treated heart defects can participate in normal activities, pursue education and careers, and have families of their own with appropriate medical guidance.

Chromosomal conditions significantly increase the risk of congenital heart defects. Down syndrome (trisomy 21) is associated with heart defects in approximately 40-50% of cases, while Edwards syndrome and Patau syndrome also carry high risks of cardiac abnormalities.

This is why detailed cardiac assessment is recommended when chromosomal conditions are diagnosed prenatally. Early screening through NIPT can identify pregnancies at increased risk, allowing for appropriate specialist cardiac evaluation and care planning.

Genetic counselling is recommended for families with a personal or family history of congenital heart defects, particularly when planning pregnancy. Counselling is especially valuable for those with aortic disease, multiple affected family members, or when other non-cardiac congenital abnormalities might be present.

For couples with known genetic defects, preimplantation genetic testing has become available as an option. Genetic counselling helps families understand recurrence risks, available screening and diagnostic options, and supports informed decision-making about family planning and pregnancy management.

Enhanced screening protocols are recommended for pregnancies at increased risk of congenital heart defects. This typically includes detailed anomaly scanning with particular attention to cardiac structures, and specialist fetal echocardiography performed by experienced practitioners using ultrasound equipment.

The timing of screening is important, with detailed cardiac assessment usually performed between 18-22 weeks of pregnancy when heart structures are sufficiently developed for comprehensive evaluation. For very high-risk cases, earlier screening may be considered, and some centres offer specialised early cardiac scanning.

Detection rates vary depending on the type of defect and the expertise of the scanning centre. Complex defects are generally easier to detect than simple defects, and some subtle abnormalities may not be visible on prenatal ultrasound. Specialist fetal echocardiography performed at experienced centres achieves higher detection rates than routine screening.

Even with the best available technology and expertise, not all heart defects can be detected prenatally. This is why postnatal screening, including the recommended pulse oximetry testing for newborns, remains an important component of comprehensive cardiac care.

Comprehensive support services are available through NHS specialist centres, charitable organisations, and support groups connecting families with similar experiences. Many hospitals provide specialist nurses and counsellors who support families through diagnosis, treatment, and ongoing care.

Educational resources help families understand their child’s condition and treatment options, while peer support groups provide valuable emotional support and practical advice. Transition services help young people move from paediatric to adult cardiac services, ensuring continuity of specialist care throughout life.

While most heart defects cannot be prevented, some risk factors can be modified to reduce the likelihood of occurrence. This includes ensuring adequate folic acid intake before conception, avoiding alcohol and smoking during pregnancy, managing diabetes effectively, and avoiding exposure to infections like rubella.

For women taking medications that may affect fetal heart development, pre-pregnancy counselling allows for medication review and optimisation of treatment regimens. Genetic counselling helps identify families at higher risk and provides information about available screening and preventive options.

The impact on daily life varies tremendously depending on the type and severity of the defect and the success of any treatments received. Many individuals with successfully treated heart defects lead completely normal lives with no activity restrictions, while others may need to modify their activities or take regular medications.

Regular follow-up with specialist cardiac services helps monitor heart function and adjust treatment as needed. Most children with heart defects can attend regular school and participate in age-appropriate activities, though some may require individual assessment for sports participation or other physical activities.

When a heart defect is diagnosed prenatally, families receive detailed counselling about the specific condition, treatment options, and long-term outlook. The medical team coordinates care with paediatric cardiology specialists and plans for delivery at a centre equipped for immediate specialist intervention if required.

Families have time to prepare emotionally and practically for their baby’s arrival, including understanding what treatments may be needed and connecting with support services. Some families may consider additional diagnostic testing to clarify the diagnosis or assess for associated conditions, while others focus on preparation for postnatal care and treatment.

This page was created using information from the following trusted medical sources:

• Congenital Heart Disease | Congenital Heart Defects | MedlinePlus
• Pregnancy and congenital heart disease – PMC
• Pregnancy in congenital heart disease: risk prediction and counselling | Heart
• Congenital heart disease – Diagnosis – NHS
• Classification: Official 1 Congenital Heart Disease Standards & Specifications
• Classification: Official 1 Paediatric Congenital Heart Disease Specification
• Clinical Guidelines and Useful information – Northwest, North Wales, Isle of Man Congenital Heart Network
• Management Guidelines for Adults with Congenital Heart …
• Congenital heart disease – NHS
• Congenital Heart Disease: Symptoms & Treatment